Abstract
Background Left ventricular (LV) global longitudinal strain (GLS) and circumferential strain (GCS), and left atrial (LA) strain (LAS) are indicators of poor clinical prognosis. However, it is unclear how they relate to each other and to LV and LA geometry. The aim was to clarify these relationships to inform clinical and research applications.
Methods Patients referred for cardiovascular magnetic resonance imaging were retrospectively identified. Univariable and multivariable linear regression models evaluated associations between GLS, GCS, LAS, LV mass, the volumes and dimensions of the LV and LA, and mitral annular plane systolic excursion (MAPSE).
Results In patients (n=66, median [interquartile range] age 62 [53–72] years, 82% male, LV ejection fraction 48 [34–56]%, range 6–69%), GLS associated with both GCS (R2=0.86, p<0.001) and LAS (R2=0.51, p<0.001), and LAS associated with GCS (R2=0.42, p<0.001). GLS, GCS, and LAS were all univariably associated with MAPSE, LV mass, and the volumes and dimensions of the LV and LA (p<0.001 for all). In multivariable analysis, GLS associated with MAPSE and LV length (R2=0.85, p<0.001); GCS with MAPSE, LV end-systolic volume, and LV mass (R2=0.80, p<0.001); and LAS with LA end-diastolic volume and MAPSE (R2=0.67, p<0.001).
Conclusions MAPSE and LV length alone can accurately estimate GLS. GLS and GCS provide similar information. LV and LA strains can be understood as geometrically coupled composite measures of MAPSE, and the size, function, and dimensions of the LV and LA. The composite of these geometrical relationships likely explains the excellent prognostic strength of strain measures.
Competing Interest Statement
All authors are employees of Karolinska University Hospital, which has a research and development agreement with Siemens regarding cardiovascular magnetic Resonance Imaging.
Funding Statement
Grant funding was provided in part by grants to MU from New South Wales Health, heart Reseach Australia, and the University of Sydney. Additional funding was provided by grants to JN from Swedish lung and heart foundation and Swedish society of medicine and Karolinska Institute.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Regionala etikprovningsnamnden Stockholm gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
